SCC445
OSUMMER.1 Mouse NRAS-Mutant Melanoma Cell Line
Faça loginpara ver os preços organizacionais e de contrato
About This Item
embalagem
vial of ≥1X10⁶ cells/vial mg
Nível de qualidade
fabricante/nome comercial
Millipore
modo de crescimento
N/A
técnica(s)
cell analysis: suitable
Condições de expedição
liquid nitrogen
temperatura de armazenamento
−196°C
Aplicação
Each vial contains 1X106 viable cells.
Cells are tested negative for infectious diseases by a Mouse Essential CLEAR Panel by Charles River Animal Diagnostic Services.
Cells are verified to be of mouse origin and negative for inter-species contamination from rat, human, chinese hamster, Golden Syrian hamster, and Non-human Primate (NHP) as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services
Cells are negative for mycoplasma contamination.
Cells are tested negative for infectious diseases by a Mouse Essential CLEAR Panel by Charles River Animal Diagnostic Services.
Cells are verified to be of mouse origin and negative for inter-species contamination from rat, human, chinese hamster, Golden Syrian hamster, and Non-human Primate (NHP) as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services
Cells are negative for mycoplasma contamination.
Early-stage melanoma can be cured by resection, but fewer treatment options are available for patients with metastatic disease. Development of resistance to targeted and immunotherapies, as well as toxicity are major problems. Along with sun exposure, sporadic genetic mutations have been associated with melanomas (1). Immunotherapy treatments targeting these genes or pathways have been proven to have significant benefits in melanoma patients by improving general response and survival.
The OSUMMER (Ohio State University and Moffitt Melanoma Exposed to Radiation) cell lines fill a previously unfilled gap in melanoma biology. The OSUMMER cell lines are syngeneic to C57BL/6 laboratory mice and have genetic profiles that are similar to human tumors, making them responsive to immunotherapy treatments. These NRAS-Mutant cell lines can be used to discover and address potential immunotherapies in NRAS-mutant human melanomas which make up an estimated 15-25% of human melanomas. These cell lines also enable in vivo testing of immunotherapies with a mouse model.
OSUMMER.1 mouse NRAS-mutant melanoma cell line was derived from a male TN mouse exposed to UVA and UVB radiation. OSUMMER.1 carries the specific NRAS mutation Q61R and can form tumors in vivo without Matrigel injection. WES revealed high SNV (Single Nucleotide variants) and low CNA (Copy Number Alterations) burden, as well as the presence of UV signature mutations. OSUMMER.1 cells express the melanoma markers PMEL and demonstrate robust growth in culture.
Source
OSUMMER.1 was derived from melanoma induced in TN (Tyr::CreER) mice exposed to UVA or UVB radiation on postnatal day 3 (2).
References
1. Lancet 2018, 392(10151): 971-984.
2. Life Sci Alliance 2021, 4(9): e202101135.
The OSUMMER (Ohio State University and Moffitt Melanoma Exposed to Radiation) cell lines fill a previously unfilled gap in melanoma biology. The OSUMMER cell lines are syngeneic to C57BL/6 laboratory mice and have genetic profiles that are similar to human tumors, making them responsive to immunotherapy treatments. These NRAS-Mutant cell lines can be used to discover and address potential immunotherapies in NRAS-mutant human melanomas which make up an estimated 15-25% of human melanomas. These cell lines also enable in vivo testing of immunotherapies with a mouse model.
OSUMMER.1 mouse NRAS-mutant melanoma cell line was derived from a male TN mouse exposed to UVA and UVB radiation. OSUMMER.1 carries the specific NRAS mutation Q61R and can form tumors in vivo without Matrigel injection. WES revealed high SNV (Single Nucleotide variants) and low CNA (Copy Number Alterations) burden, as well as the presence of UV signature mutations. OSUMMER.1 cells express the melanoma markers PMEL and demonstrate robust growth in culture.
Source
OSUMMER.1 was derived from melanoma induced in TN (Tyr::CreER) mice exposed to UVA or UVB radiation on postnatal day 3 (2).
References
1. Lancet 2018, 392(10151): 971-984.
2. Life Sci Alliance 2021, 4(9): e202101135.
Características e benefícios
The OSUMMER.1 cell line carries the specific NRAS mutation Q61R and may be used to create syngeneic mouse melanoma models.
Armazenamento e estabilidade
The cells should be stored in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
Outras notas
This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.
Exoneração de responsabilidade
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
produto relacionado
Nº do produto
Descrição
Preços
Código de classe de armazenamento
10 - Combustible liquids
Classe de risco de água (WGK)
WGK 2
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Certificados de análise (COA)
Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica